TOVX Theriva Biologics Inc
Theriva Biologics Inc (TOVX) is expected to report earnings on November 10, 2026, after the market close.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Theriva Biologics Inc
Theriva Biologics Inc. is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company's lead candidate includes VCN-01, SYN-004 and SYN-020. Theriva Biologics Inc., formerly known as Synthetic Biologics Inc., is based in ROCKVILLE, Md.
Charts powered in part by Lightweight Charts™ by TradingView.